Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 1/2021

Open Access 01-01-2021 | Literatur kommentiert

Randomisierte Phase-IIB-Studie zur Protonentherapie vs. intensitätsmodulierte Photonentherapie für lokal fortgeschrittene Ösophaguskarzinome

Author: Prof. Dr. med. Mechthild Krause

Published in: Strahlentherapie und Onkologie | Issue 1/2021

Login to get access

Auszug

Diese randomisierte Studie vergleicht die Gesamttoxizitätsbelastung (TTB) und das progressionsfreie Überleben (PFS) bei Protonenbestrahlung („proton beam therapy“ [PBT]) und Photonen-Intensitätsmodulierter Strahlentherapie (IMRT) für Patienten mit lokal fortgeschrittenem Ösophaguskarzinom. …
Literature
1.
Lin SH et al (2020) Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer. J Clin Oncol 38(14):1569–1579CrossRef
2.
Wang X et al (2020) Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer. J Thorac Oncol 15(10):1682–1690CrossRef
3.
Wang J et al (2013) Predictors of postoperative complications after trimodality therapy for esophageal cancer. Int J Radiat Oncol Biol Phys 86(5):885–891CrossRef
4.
Lin SH et al (2017) Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer. Radiother Oncol 123(3):376–381CrossRef
Metadata
Title
Randomisierte Phase-IIB-Studie zur Protonentherapie vs. intensitätsmodulierte Photonentherapie für lokal fortgeschrittene Ösophaguskarzinome
Author
Prof. Dr. med. Mechthild Krause
Publication date
01-01-2021
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 1/2021
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-020-01714-9

Other articles of this Issue 1/2021

Strahlentherapie und Onkologie 1/2021 Go to the issue

Original Article

FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro

Original Article

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial

Original Article

Cardiac serum marker alterations after intraoperative radiotherapy with low-energy x-rays in early breast cancer as an indicator of possible cardiac toxicity

Original Article

Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma

Original Article

R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial

Literatur kommentiert

Neoadjuvante Radiochemotherapie verbessert bei resektablen und grenzwertig resezierbaren Pankreaskarzinomen die onkologischen Ergebnisse, bei resezierbaren aber nicht das Gesamtüberleben